The role of Interleukin 6 inhibitors in therapy of severe COVID-19 - «Национальный агрегатор открытых репозиториев российских университетов» (НОРА)

Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

расширенный поиск

The role of Interleukin 6 inhibitors in therapy of severe COVID-19

Дата публикации: 2021-04-27

Дата публикации в реестре: 2021-10-05T18:21:47Z

Аннотация:

Ключевые слова:
cytokine receptor antagonist, gamma interferon, immunosuppressive agent, interleukin 1, interleukin 17, interleukin 18, interleukin 6, monoclonal antibody, tocilizumab, tumor necrosis factor, antiinflammatory agent, cytokine, interleukin 6, artificial ventilation, complement inhibition, complement system, coronavirus disease 2019, cytokine storm, disease severity, drug efficacy, human, immune response, immunopathogenesis, immunotherapy, mortality rate, pathogenesis, personalized medicine, priority journal, Review, Severe acute respiratory syndrome coronavirus 2, Betacoronavirus, complication, Coronavirus infection, cytokine release syndrome, immunology, isolation and purification, pandemic, prognosis, severity of illness index, virology, virus pneumonia, Anti-Inflammatory Agents, Betacoronavirus, Coronavirus Infections, Cytokine Release Syndrome, Cytokines, Humans, Interleukin-6, Pandemics, Pneumonia, Viral, Prognosis, Severity of Illness Index

Тип: info:eu-repo/semantics/journal-article

Связанные документы (рекомендация CORE)